<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cell and Tissue Biology</journal-id><journal-title-group><journal-title xml:lang="en">Cell and Tissue Biology</journal-title><trans-title-group xml:lang="ru"><trans-title>Цитология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0041-3771</issn><issn publication-format="electronic">3034-6061</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">669565</article-id><article-id pub-id-type="doi">10.31857/S0041377123020062</article-id><article-id pub-id-type="edn">LWRDIV</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Activation of Endogenous Mesenchymal Stromal Cells as an Approach to Tissue Regeneration</article-title><trans-title-group xml:lang="ru"><trans-title>Активация эндогенных мезенхимных стромальных клеток как подход к регенерации тканей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Payushina</surname><given-names>O. V.</given-names></name><name xml:lang="ru"><surname>Паюшина</surname><given-names>О. В.</given-names></name></name-alternatives><email>payushina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tsomartova</surname><given-names>D. A.</given-names></name><name xml:lang="ru"><surname>Цомартова</surname><given-names>Д. А.</given-names></name></name-alternatives><email>payushina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chereshneva</surname><given-names>Ye. V.</given-names></name><name xml:lang="ru"><surname>Черешнева</surname><given-names>Е. В.</given-names></name></name-alternatives><email>payushina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ivanova</surname><given-names>M. Yu.</given-names></name><name xml:lang="ru"><surname>Иванова</surname><given-names>М. Ю.</given-names></name></name-alternatives><email>payushina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lomanovskaya</surname><given-names>T. A.</given-names></name><name xml:lang="ru"><surname>Ломановская</surname><given-names>Т. А.</given-names></name></name-alternatives><email>payushina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pavlova</surname><given-names>M. S.</given-names></name><name xml:lang="ru"><surname>Павлова</surname><given-names>М. С.</given-names></name></name-alternatives><email>payushina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kuznetsov</surname><given-names>S. L.</given-names></name><name xml:lang="ru"><surname>Кузнецов</surname><given-names>С. Л.</given-names></name></name-alternatives><email>payushina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-03-01" publication-format="electronic"><day>01</day><month>03</month><year>2023</year></pub-date><volume>65</volume><issue>2</issue><fpage>119</fpage><lpage>130</lpage><history><date date-type="received" iso-8601-date="2025-02-27"><day>27</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, О.В. Паюшина, Д.А. Цомартова, Е.В. Черешнева, М.Ю. Иванова, Т.А. Ломановская, М.С. Павлова, С.Л. Кузнецов</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, О.В. Паюшина, Д.А. Цомартова, Е.В. Черешнева, М.Ю. Иванова, Т.А. Ломановская, М.С. Павлова, С.Л. Кузнецов</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">О.В. Паюшина, Д.А. Цомартова, Е.В. Черешнева, М.Ю. Иванова, Т.А. Ломановская, М.С. Павлова, С.Л. Кузнецов</copyright-holder><copyright-holder xml:lang="ru">О.В. Паюшина, Д.А. Цомартова, Е.В. Черешнева, М.Ю. Иванова, Т.А. Ломановская, М.С. Павлова, С.Л. Кузнецов</copyright-holder></permissions><self-uri xlink:href="https://vietnamjournal.ru/0041-3771/article/view/669565">https://vietnamjournal.ru/0041-3771/article/view/669565</self-uri><abstract xml:lang="en"><p id="idm45181322543280">Mesenchymal stromal cells (MSCs) which have a complex pro-regenerative effect on damaged tissues represent a promising resource for cell therapy for a wide range of diseases. However, transplantation of autologous or donor MSCs to a patient is associated with a number of problems, such as variability of cell properties depending on their source and cultivation conditions, a decrease in their therapeutic potential and the possibility of acquiring immunogenicity or tumorigenicity during <italic>in vitro</italic> expansion, and the invasiveness of the isolation procedure. One of the ways to avoid these problems can be the impact on endogenous MSCs by stimulating their directed migration into tissue defects, without the need for extraction from the body, <italic>in vitro</italic> cultivation and reintroduction to the patient. This review discusses approaches to activating the mobilization of MSCs from tissue niches and/or stimulating their migration to the target area, which can be considered as a safer, and possibly more effective alternative to MSC transplantation.</p></abstract><trans-abstract xml:lang="ru"><p id="idm45181322541584">Мезенхимные стромальные клетки (МСК), оказывающие комплексное прорегенеративное влияние на поврежденные ткани, представляют собой перспективный ресурс для клеточной терапии широкого спектра заболеваний. Однако трансплантация пациенту аутологичных или донорских МСК сопряжена с рядом проблем, таких как вариабельность свойств клеток в зависимости от источника и условий культивирования, снижение их терапевтического потенциала и вероятность приобретения иммуногенности либо туморогенности в ходе экспансии <italic>in vitro</italic>, инвазивность процедуры выделения. Одним из способов избежать этих проблем может служить воздействие на эндогенные МСК путем стимуляции их направленной миграции в тканевые дефекты без необходимости извлечения из организма, размножения <italic>in vitro</italic> и обратного введения пациенту. В настоящем обзоре рассмотрены подходы к активации мобилизации МСК из тканевых ниш и (или) стимуляции их миграции в целевую область, которые могут рассматриваться в качестве более безопасной, а возможно, и более эффективной альтернативы трансплантации МСК.</p></trans-abstract><kwd-group xml:lang="en"><kwd>mesenchymal stromal cells</kwd><kwd>regenerative medicine</kwd><kwd>mobilization</kwd><kwd>migration</kwd><kwd>chemoattractants</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>мезенхимные стромальные клетки</kwd><kwd>регенеративная медицина</kwd><kwd>мобилизация</kwd><kwd>миграция</kwd><kwd>хемоаттрактанты</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Andrzejewska A., Lukomska B., Janowski M. 2019. Concise review: mesenchymal stem cells: from roots to boost. Stem Cells. V. 37. P. 855. https://doi.org/10.1002/stem.3016</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., Rovner A., Ellis S.G., Thomas J.D., DiCorleto P.E., Topol E.J., Penn M.S. 2003. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. V. 362. P. 697. https://doi.org/10.1016/S0140-6736(03)14232-8</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Balseanu A.T., Buga A.M., Catalin B., Wagner D.C., Boltze J., Zagrean A.M., Reymann K., Schaebitz W., Popa-Wagner A. 2014. Multimodal approaches for regenerative stroke therapies: combination of granulocyte colony-stimulating factor with bone marrow mesenchymal stem cells is not superior to G-CSF alone. Front. Aging Neurosci. V. 23. P. 130. https://doi.org/10.3389/fnagi.2014.00130</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Bayo J., Real A., Fiore E.J., Malvicini M., Sganga L., Bolontrade M., Andriani O., Bizama C., Fresno C., Podhajcer O., Fernandez E., Gidekel M., Mazzolini G.D., García M.G. 2016. IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness. Oncotarget. V. 8. P. 80235. https://doi.org/10.18632/oncotarget.10288</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Bradley M.J., Vicente D.A., Bograd B.A., Sanders E.M., Leonhardt C.L., Elster E.A., Davis T.A. 2017. Host responses to concurrent combined injuries in non-human primates. J. Inflamm. (Lond.). V. 14. P. 23. https://doi.org/10.1186/s12950-017-0170-7</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Bui K.C., Senadheera D., Wang X., Hendrickson B., Friedlich P., Lutzko C. 2010. Recovery of multipotent progenitors from the peripheral blood of patients requiring extracorporeal membrane oxygenation support. Am. J. Respir. Crit. Care Med. V. 181. P. 226. https://doi.org/10.1164/rccm.200812-1901OC</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Burks S.R., Nagle M.E., Bresler M.N., Kim S.J., Star R.A., Frank J.A. 2018. Mesenchymal stromal cell potency to treat acute kidney injury increased by ultrasound-activated interferon-γ/interleukin-10 axis. J. Cell. Mol. Med. V. 22. P. 6015. https://doi.org/10.1111/jcmm.13874</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Cai X., Yang F., Walboomers X.F., Wang Y., Jansen J.A., van den Beucken J.J.J.P., Plachokova A.S. 2018. Periodontal regeneration via chemoattractive constructs. J. Clin. Periodontol. V. 45. P. 851. https://doi.org/10.1111/jcpe.12928</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Calle A., Barrajón-Masa C., Gómez-Fidalgo E., Martín-Lluch M., Cruz-Vigo P., Sánchez-Sánchez R., Ramírez M.Á. 2018. Iberian pig mesenchymal stem/stromal cells from dermal skin, abdominal and subcutaneous adipose tissues, and peripheral blood: in vitro characterization and migratory properties in inflammation. Stem Cell Res. Ther. V. 9. P. 178. https://doi.org/10.1186/s13287-018-0933-y</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Chen P., Tao J., Zhu S., Cai Y., Mao Q., Yu D., Dai J., Ouyang H. 2015. Radially oriented collagen scaffold with SDF-1 promotes osteochondral repair by facilitating cell homing. Biomaterials. V. 39. P. 114. https://doi.org/10.1016/j.biomaterials.2014.10.049</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Chen Z., Ren X., Ren R., Wang Y., Shang J. 2021. The combination of G-CSF and AMD3100 mobilizes bone marrow-derived stem cells to protect against cisplatin-induced acute kidney injury in mice. Stem Cell Res. Ther. V. 12. P. 209. https://doi.org/10.1186/s13287-021-02268-y</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Chuma H., Mizuta H., Kudo S., Takagi K., Hiraki Y. 2004. One day exposure to FGF-2 was sufficient for the regenerative repair of full-thickness defects of articular cartilage in rabbits. Osteoarthritis Cartilage. V. 12. P. 834. https://doi.org/10.1016/j.joca.2004.07.003</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Churchman S.M., Jones E.A., Roshdy T., Cox G., Boxall S.A., McGonagle D., Giannoudis P.V. 2020. Transient existence of circulating mesenchymal stem cells in the deep veins in humans following long bone intramedullary reaming. J. Clin. Med. V. 9. P. 968. https://doi.org/10.3390/jcm9040968</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Deng J., Zou Z.M., Zhou T.L., Su Y.P., Ai G.P., Wang J.P., Xu H., Dong S.W. 2011. Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue. Neurol. Sci. V. 32. P. 641. https://doi.org/10.1007/s10072-011-0608-2</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Deng M., Mei T., Hou T., Luo K., Luo F., Yang A., Yu B., Pang H., Dong S., Xu J. 2017. TGFβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration. Stem Cell Res. Ther. V. 8. P. 258. https://doi.org/10.1186/s13287-017-0693-0</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Dhar M., Neilsen N., Beatty K., Eaker S., Adair H., Geiser D. 2012. Equine peripheral blood-derived mesenchymal stem cells: isolation, identification, trilineage differentiation and effect of hyperbaric oxygen treatment. Equine Vet. J. V. 44. P. 600. https://doi.org/10.1111/j.2042-3306.2011.00536.x</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Dubon M.J., Yu J., Choi S., Park K.S. 2018. Transforming growth factor β induces bone marrow mesenchymal stem cell migration via noncanonical signals and N-cadherin. J. Cell. Physiol. V. 233. P. 201. https://doi.org/10.1002/jcp.25863</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Dubon M.J., Park K.S. 2016. The mechanisms of substance P-mediated migration of bone marrow-derived mesenchymal stem cell-like ST2 cells. Int. J. Mol. Med. V. 37. P. 1105. https://doi.org/10.3892/ijmm.2016.2496</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Dwyer R.M., Potter-Beirne S.M., Harrington K.A., Lowery A.J., Hennessy E., Murphy J.M., Barry F.P., O’Brien T., Kerin M.J. 2007. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin. Cancer. Res. V. 13. P. 5020. https://doi.org/10.1158/1078-0432.CCR-07-0731</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Emamnejad R., Sahraian M., Shakiba Y., Salehi Z., Masoomi A., Imani D., Najafi F., Laribi B., Shirzad H., Izad M. 2019. Circulating mesenchymal stem cells, stromal derived factor (SDF)-1 and IP-10 levels increased in clinically active multiple sclerosis patients but not in clinically stable patients treated with beta interferon. Mult. Scler. Relat. Disord. V. 35. P. 233. https://doi.org/10.1016/j.msard.2019.08.013</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Fan W., Yuan L., Li J., Wang Z., Chen J., Guo C., Mo X., Yan Z. 2020. Injectable double-crosslinked hydrogels with kartogenin-conjugated polyurethane nano-particles and transforming growth factor β3 for in situ cartilage regeneration. Mater. Sci. Eng. C Mater. Biol. Appl. V. 110. P. 110705. https://doi.org/10.1016/j.msec.2020.110705</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Fellous T.G., Redpath A.N., Fleischer M.M., Gandhi S., Hartner S.E., Newton M.D., François M., Wong S.P., Gowers K.H.C., Fahs A.M., Possley D.R., Bonnet D., Urquhart P., Nicolaou A., Baker K.C. et al. 2020. Pharmacological tools to mobilise mesenchymal stromal cells into the blood promote bone formation after surgery. NPJ Regen. Med. V. 5. P. 3. https://doi.org/10.1038/s41536-020-0088-1</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Fujita K., Kuge K., Ozawa N., Sahara S., Zaiki K., Nakaoji K., Hamada K., Takenaka Y., Tanahashi T., Tamai K., Kaneda Y., Maeda A. 2015. Cinnamtannin B-1 promotes migration of mesenchymal stem cells and accelerates wound healing in mice. PLoS One. V. 10. P. e0144166. https://doi.org/10.1371/journal.pone.0144166</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Fujita R., Tamai K., Aikawa E., Nimura K., Ishino S., Kikuchi Y., Kaneda Y. 2015. Endogenous mesenchymal stromal cells in bone marrow are required to preserve muscle function in mdx mice. Stem Cells. V. 33. P. 962. https://doi.org/10.1002/stem.1900</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Furumoto T., Ozawa N., Inami Y., Toyoshima M., Fujita K., Zaiki K., Sahara S., Akita M., Kitamura K., Nakaoji K., Hamada K., Tamai K., Kaneda Y., Maeda A. 2014. Mallotus philippinensis bark extracts promote preferential migration of mesenchymal stem cells and improve wound healing in mice. Phytomedicine. V. 21. P. 247. https://doi.org/10.1016/j.phymed.2013.09.003</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Garcia N.P., de Leon E.B., da Costa A.G., Tarragô A.M., Pimentel J.P., Fraporti L., de Araujo F.F., Campos F.M., Teixeira-Carvalho A., Martins-Filho O.A., Malheiro A. 2015. Kinetics of mesenchymal and hematopoietic stem cells mobilization by G-CSF and its impact on the cytokine microenvironment in primary cultures. Cell. Immunol. V. 293. P. 1. https://doi.org/10.1016/j.cellimm.2014.09.006</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Ge T., Yu Q., Liu W., Cong L., Liu L., Wang Y., Zhou L., Lin D. 2016. Characterization of bone marrow-derived mesenchymal stem cells from dimethyloxallyl glycine-preconditioned mice: evaluation of the feasibility of dimethyloxallyl glycine as a mobilization agent. Mol. Med. Rep. V. 13. P. 3498. https://doi.org/10.3892/mmr.2016.4945</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Ghazanfari T., Ghaffarpour S., Kariminia A., Salehi E., Hashemi S.M., Ardestani S.K., Gohari Moghadam K., Mirsharif E.S., Dilmaghanian R., Fadaei A., Faghihzadeh S. 2019. Circulating mesenchymal stem cells in sulfur mustard-exposed patients with long-term pulmonary complications. Toxicol. Lett. V. 312. P. 188. https://doi.org/10.1016/j.toxlet.2019.05.015</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Gomez-Salazar M., Gonzalez-Galofre Z.N., Casamitjana J., Crisan M., James A.W., Péault B. 2020. Five decades later, are mesenchymal stem cells still relevant? Front. Bioeng. Biotechnol. V. 8. P. 148. https://doi.org/10.3389/fbioe.2020.00148</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Guo J., Zhang H., Xiao J., Wu J., Ye Y., Li Z., Zou Y., Li X. 2013. Monocyte chemotactic protein-1 promotes the myocardial homing of mesenchymal stem cells in dilated cardiomyopathy. Int. J. Mol. Sci. V. 14. P. 8164. https://doi.org/10.3390/ijms14048164</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Hannoush E.J., Sifri Z.C., Elhassan I.O., Mohr A.M., Alzate W.D., Offin M., Livingston D.H. 2011. Impact of enhanced mobilization of bone marrow derived cells to site of injury. J. Trauma. V. 71. P. 283. https://doi.org/10.1097/TA.0b013e318222f380</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Heino T.J., Alm J.J., Moritz N., Aro H.T. 2012. Comparison of the osteogenic capacity of minipig and human bone marrow-derived mesenchymal stem cells. J. Orthop. Res. V. 30. P. 1019. https://doi.org/10.1002/jor.22049</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Hong H.S., Lee J., Lee E., Kwon Y.S., Lee E., Ahn W., Jiang M.H., Kim J.C., Son Y. 2009. A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells. Nat Med. V. 15. P. 425. https://doi.org/10.1038/nm.1909</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Hong H.S., Son Y. 2014. Substance P ameliorates collagen II-induced arthritis in mice via suppression of the inflammatory response. Biochem. Biophys. Res. Commun. V. 453. P. 179. https://doi.org/10.1016/j.bbrc.2014.09.090</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Hoogduijn M.J., Verstegen M.M., Engela A.U., Korevaar S.S., Roemeling-van Rhijn M., Merino A., Franquesa M., de Jonge J., Ijzermans J.N., Weimar W., Betjes M.G., Baan C.C., van der Laan L.J. 2014. No evidence for circulating mesenchymal stem cells in patients with organ injury. Stem Cells Dev. V. 23. P. 2328. https://doi.org/10.1089/scd.2014.0269</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Hu C., Yong X., Li C., Lü M., Liu D., Chen L., Hu J., Teng M., Zhang D., Fan Y., Liang G. 2013. CXCL12/CXCR4 axis promotes mesenchymal stem cell mobilization to burn wounds and contributes to wound repair. J. Surg. Res. V. 183. P. 427. https://doi.org/10.1016/j.jss.2013.01.019</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Iinuma S., Aikawa E., Tamai K., Fujita R., Kikuchi Y., Chino T., Kikuta J., McGrath J.A., Uitto J., Ishii M., Iizuka H., Kaneda Y. 2015. Transplanted bone marrow-derived circulating PDGFRα+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft. J. Immunol. V. 194. P. 1996. https://doi.org/10.4049/jimmunol.1400914</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Ishikawa M., Ito H., Kitaori T., Murata K., Shibuya H., Furu M., Yoshitomi H., Fujii T., Yamamoto K., Matsuda S. 2014. MCP/CCR2 signaling is essential for recruitment of mesenchymal progenitor cells during the early phase of fracture healing. PLoS One. V. 9. P. e104954. https://doi.org/10.1371/journal.pone.0104954</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Iso Y., Yamaya S., Sato T., Poole C.N., Isoyama K., Mimura M., Koba S., Kobayashi Y., Takeyama Y., Spees J.L, Suzuki H. 2012. Distinct mobilization of circulating CD271+ mesenchymal progenitors from hematopoietic progenitors during aging and after myocardial infarction. Stem Cells Transl. Med. V. 1. P. 462. https://doi.org/10.5966/sctm.2011-0051</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Jang K.W., Tu T.W., Rosenblatt R.B., Burks S.R., Frank J.A. 2020. MR-guided pulsed focused ultrasound improves mesenchymal stromal cell homing to the myocardium. J. Cell. Mol. Med. V. 24. P. 13278. https://doi.org/10.1111/jcmm.15944</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Jin W., Liang X., Brooks A., Futrega K., Liu X., Doran M.R., Simpson M.J., Roberts M.S., Wang H. 2018. Modelling of the SDF-1/CXCR4 regulated in vivo homing of therapeutic mesenchymal stem/stromal cells in mice. Peer J. V. 6. P. e6072. https://doi.org/10.7717/peerj.6072</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Kamali A., Oryan A., Hosseini S., Ghanian M.H., Alizadeh M., Baghaban Eslaminejad M., Baharvand H. 2019. Cannabidiol-loaded microspheres incorporated into osteoconductive scaffold enhance mesenchymal stem cell recruitment and regeneration of critical-sized bone defects. Mater. Sci. Eng. C Mater. Biol. Appl. V. 101. P. 64. https://doi.org/10.1016/j.msec.2019.03.070</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Khaldoyanidi S. 2008. Directing stem cell homing. Cell Stem Cell. V. 6. P. 198. https://doi.org/10.1016/j.stem.2008.02.012</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Kim J., Kim N.K., Park S.R., Choi B.H. 2018a. GM-CSF enhances mobilization of bone marrow mesenchymal stem cells via a CXCR4-medicated mechanism. Tiss. Eng. Regen. Med. V. 16. P. 59. https://doi.org/10.1007/s13770-018-0163-5</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Kim J.E., Lee J.H., Kim S.H., Jung Y. 2018b. Skin regeneration with self-assembled peptide hydrogels conjugated with substance P in a diabetic rat model. Tissue Eng. Part A. V. 24. P. 21. https://doi.org/10.1089/ten.TEA.2016.0517</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Kim K., Lee C.H., Kim B.K., Mao J.J. 2010. Anatomically shaped tooth and periodontal regeneration by cell homing. J. Dent. Res. V. 89. P. 842. https://doi.org/10.1177/0022034510370803</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Kim S.J., Kim J.E., Kim S.H., Kim S.J., Jeon S.J., Kim S.H., Jung Y. 2016. Therapeutic effects of neuropeptide substance P coupled with self-assembled peptide nanofibers on the progression of osteoarthritis in a rat model. Biomaterials. V. 74. P. 119. https://doi.org/10.1016/j.biomaterials.2015.09.040</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Ko I.K., Ju Y.M., Chen T., Atala A., Yoo J.J., Lee S.J. 2012. Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration. FASEB J. V. 26. P. 158. https://doi.org/10.1096/fj.11-182998</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Koerner J., Nesic D., Romero J. D., Brehm W., Mainil–Varlet P., Grogan S.P. 2006. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells. Stem Cells. V. 24. P. 1613. https://doi.org/10.1634/stemcells.2005-0264</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Krstić J., Obradović H., Jauković A., Okić-Đorđević I., Trivanović D., Kukolj T., Mojsilović S., Ilić V., Santibañez J.F., Bugarski D. 2015. Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration. Biochim. Biophys. Acta. V. 1853. P. 431. https://doi.org/10.1016/j.bbamcr.2014.11.025</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Kumar S., Ponnazhagan S. 2012. Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect. Bone. V. 50. P. 1012. https://doi.org/10.1016/j.bone.2012.01.027</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Kuznetsov S.A., Mankani M.H., Leet A.I., Ziran N., Gronthos S., Robey P.G. 2007. Circulating connective tissue precursors: extreme rarity in humans and chondrogenic potential in guinea pigs. Stem Cells. V. 25. P. 1830. https://doi.org/10.1634/stemcells.2007-0140</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Lan Y., Kodati S., Lee H.S., Omoto M., Jin Y., Chauhan S.K. 2012. Kinetics and function of mesenchymal stem cells in corneal injury. Invest. Ophthalmol. Vis. Sci. V. 53. P. 3638. https://doi.org/10.1167/iovs.11-9311</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Lang H.M., Schnabel L.V., Cassano J.M., Fortier L.A. 2017. Effect of needle diameter on the viability of equine bone marrow derived mesenchymal stem cells. Vet. Surg. V. 46. P. 731. https://doi.org/10.1111/vsu.12639</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Lee C.H., Cook J.L., Mendelson A., Moioli E.K., Yao H., Mao J.J. 2010. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet. V. 376. P. 440. https://doi.org/10.1016/S0140-6736(10)60668-X</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Levy O., Kuai R., Siren E.M.J., Bhere D., Milton Y., Nissar N., De Biasio M., Heinelt M., Reeve B., Abdi R., Alturki M., Fallatah M., Almalik A., Alhasan A.H., Shah K. et al. 2020. Shattering barriers toward clinically meaningful MSC therapies. Sci. Adv. V. 6. P. eaba6884. https://doi.org/10.1126/sciadv.aba6884</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Li Y., Dong Y., Ran Y., Zhang Y., Wu B., Xie J., Cao Y., Mo M., Li S., Deng H., Hao W., Yu S., Wu Y. 2021. Three-dimensional cultured mesenchymal stem cells enhance repair of ischemic stroke through inhibition of microglia. Stem Cell Res. Ther. V. 12. P. 358. https://doi.org/10.1186/s13287-021-02416-4</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Lin W., Xu L., Lin S., Shi L., Wang B., Pan Q., Lee W.Y.W., Li G. 2019. Characterisation of multipotent stem cells from human peripheral blood using an improved protocol. J. Orthop. Translat. V. 19. P. 18. https://doi.org/10.1016/j.jot.2019.02.003</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Lin W., Xu L., Zwingenberger S., Gibon E., Goodman S.B., Li G. 2017. Mesenchymal stem cells homing to improve bone healing. J. Orthop. Translat. V. 9. P. 19. https://doi.org/10.1016/j.jot.2017.03.002</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Liu L., Yu Q., Fu S., Wang B., Hu K., Wang L., Hu Y., Xu Y., Yu X., Huang H. 2018. CXCR4 antagonist AMD3100 promotes mesenchymal stem cell mobilization in rats preconditioned with the hypoxia-mimicking agent cobalt chloride. Stem Cells Dev. V. 27. P. 466. https://doi.org/10.1089/scd.2017.0191</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Liu L., Yu Q., Hu K., Wang B., Zhang Y., Xu Y., Fu S., Yu X., Huang H. 2016. Electro-acupuncture promotes endogenous multipotential mesenchymal stem cell mobilization into the peripheral blood. Cell. Physiol. Biochem. V. 38. P. 1605. https://doi.org/10.1159/000443101</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Liu L., Yu Q., Lin J., Lai X., Cao W., Du K., Wang Y., Wu K., Hu Y., Zhang L., Xiao H., Duan Y., Huang H. 2011. Hypoxia-inducible factor-1α is essential for hypoxia-induced mesenchymal stem cell mobilization into the peripheral blood. Stem Cells Dev. V. 20. P. 1961. https://doi.org/10.1089/scd.2010.0453</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Lorsung R.M., Rosenblatt R.B., Cohen G., Frank J.A., Burks S.R. 2020. Acoustic radiation or cavitation forces from therapeutic ultrasound generate prostaglandins and increase mesenchymal stromal cell homing to murine muscle. Front. Bioeng. Biotechnol. V. 8. P. 870. https://doi.org/10.3389/fbioe.2020.00870</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Maeda A. 2020. Recruitment of mesenchymal stem cells to damaged sites by plant-derived components. Front. Cell Dev. Biol. V. 8. P. 437. https://doi.org/10.3389/fcell.2020.00437</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Maerz T., Fleischer M., Newton M.D., Davidson A., Salisbury M., Altman P., Kurdziel M.D., Anderson K., Bedi A., Baker K.C. 2017. Acute mobilization and migration of bone marrow-derived stem cells following anterior cruciate ligament rupture. Osteoarthritis Cartilage. V. 25. P. 1335. https://doi.org/10.1016/j.joca.2017.03.004</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Mansilla E., Marín G.H., Drago H., Sturla F., Salas E., Gardiner C., Bossi S., Lamonega R., Guzmán A., Nuñez A., Gil M.A., Piccinelli G., Ibar R., Soratti C. 2006. Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant. Proc. V. 38. P. 967. https://doi.org/10.1016/j.transproceed.2006.02.053</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Marketou M.E., Parthenakis F.I., Kalyva A., Pontikoglou C., Maragkoudakis S., Kontaraki J.E., Zacharis E.A., Patrianakos A., Chlouverakis G., Papadaki H.A., Vardas P.E. 2015. Circulating mesenchymal stem cells in patients with hypertrophic cardiomyopathy. Cardiovasc. Pathol. V. 24. P. 149. https://doi.org/10.1016/j.carpath.2015.02.005</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Meeson R., Sanghani-Keri A., Coathup M., Blunn G. 2019. VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing. J. Orthop. Res. V. 37. P. 1294. https://doi.org/10.1002/jor.24164</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Mi L., Liu H., Gao Y., Miao H., Ruan J. 2017. Injectable nanoparticles/hydrogels composite as sustained release system with stromal cell-derived factor-1α for calvarial bone regeneration. Int. J. Biol. Macromol. V. 101. P. 341. https://doi.org/10.1016/j.ijbiomac.2017.03.098</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Nam D., Park A., Dubon M.J., Yu J., Kim W., Son Y., Park K.S. 2020. Coordinated regulation of mesenchymal stem cell migration by various chemotactic stimuli. Int. J. Mol. Sci. V. 21. P. 8561. https://doi.org/10.3390/ijms21228561</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Nitzsche F., Müller C., Lukomska B., Jolkkonen J., Deten A., Boltze J. 2017. Concise review: MSC adhesion cascade-insights into homing and transendothelial migration. Stem Cells. V. 35. P. 1446. https://doi.org/10.1002/stem.2614</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Oh E.J., Lee H.W., Kalimuthu S., Kim T.J., Kim H.M., Baek S.H., Zhu L., Oh J.M., Son S.H., Chung H.Y., Ahn B.C. 2018. In vivo migration of mesenchymal stem cells to burn injury sites and their therapeutic effects in a living mouse model. J. Control. Release. V. 279. P. 79. https://doi.org/10.1016/j.jconrel.2018.04.020</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Pan Q., Fouraschen S.M., de Ruiter P.E., Dinjens W.N., Kwekkeboom J., Tilanus H.W., van der Laan L.J. 2014. Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells. Exp. Biol. Med. (Maywood). V. 239. P. 105. https://doi.org/10.1177/1535370213506802</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Patry C., Doniga T., Lenz F., Viergutz T., Weiss C., Tönshoff B., Kalenka A., Yard B., Krebs J., Schaible T., Beck G., Rafat N. 2020. Increased mobilization of mesenchymal stem cells in patients with acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation. PLoS One. V. 15. P. e0227460. https://doi.org/10.1371/journal.pone.0227460</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Patry C., Stamm D., Betzen C., Tönshoff B., Yard B.A., Beck G.C., Rafat N. 2018. CXCR-4 expression by circulating endothelial progenitor cells and SDF-1 serum levels are elevated in septic patients. J. Inflamm. (Lond.). V. 15. P. 10. https://doi.org/10.1186/s12950-018-0186-7</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Pavon L.F., Sibov T.T., de Souza A.V., da Cruz E.F., Malheiros S.M.F., Cabral F.R., de Souza J.G., Boufleur P., de Oliveira D.M., de Toledo S.R.C., Marti L.C., Malheiros J.M., Paiva F.F., Tannús A., de Oliveira S.M. et al. 2018. Tropism of mesenchymal stem cell toward CD133+ stem cell of glioblastoma in vitro and promote tumor proliferation in vivo. Stem Cell Res. Ther. V. 9. P. 310. https://doi.org/10.1186/s13287-018-1049-0</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Pereira C.L., Gonçalves R.M., Peroglio M., Pattappa G., D’Este M., Eglin D., Barbosa M.A., Alini M., Grad S. 2014. The effect of hyaluronan-based delivery of stromal cell-derived factor-1 on the recruitment of MSCs in degenerating intervertebral discs. Biomaterials. V. 35. P. 8144. https://doi.org/10.1016/j.biomaterials.2014.06.017</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Popielarczyk T.L., Huckle W.R., Barrett J.G. 2019. Human bone marrow-derived mesenchymal stem cells home via the PI3K-Akt, MAPK, and Jak/Stat signaling pathways in response to platelet-derived growth factor. Stem Cells Dev. V. 28. P. 1191. https://doi.org/10.1089/scd.2019.0003</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Ries C., Egea V., Karow M., Kolb H., Jochum M., Neth P. 2007. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood. V. 109. P. 4055. https://doi.org/10.1182/blood-2006-10-051060</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Rochefort G.Y., Delorme B., Lopez A., Hérault O., Bonnet P., Charbord P., Eder V., Domenech J. 2006. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells. V. 24. P. 2202. https://doi.org/10.1634/stemcells.2006-0164</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Sackstein R., Merzaban J.S., Cain D.W., Dagia N.M., Spencer J.A., Lin C.P., Wohlgemuth R. 2008. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat. Med. V. 14. P. 181. https://doi.org/10.1038/nm1703</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Sasaki M., Abe R., Fujita Y., Ando S., Inokuma D., Shimizu H. 2008. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J. Immunol. V. 180. P. 2581. https://doi.org/10.4049/jimmunol.180.4.2581</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Sasaki T., Fukazawa R., Ogawa S., Kanno S., Nitta T., Ochi M., Shimizu K. 2007. Stromal cell-derived factor-1alpha improves infarcted heart function through angiogenesis in mice. Pediatr. Int. V. 49. P. 966. https://doi.org/10.1111/j.1442-200X.2007.02491.x</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Schenk S., Mal N., Finan A., Zhang M., Kiedrowski M., Popovic Z., McCarthy P.M., Penn M.S. 2007. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells. V. 25. P. 245. https://doi.org/10.1634/stemcells.2006-0293</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>Schmidt-Lucke C., Escher F., Van Linthout S., Kühl U., Miteva K., Ringe J., Zobel T., Schultheiss H.P., Tschöpe C. 2015. Cardiac migration of endogenous mesenchymal stromal cells in patients with inflammatory cardiomyopathy. Mediators Inflamm. V. 2015. P. 308 185. https://doi.org/10.1155/2015/308185</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Selma J.M., Das A., Awojoodu A.O., Wang T., Kaushik A.P., Cui Q., Song H., Ogle M.E., Olingy C.E., Pendleton E.G., Tehrani K.F., Mortensen L.J., Botchwey E.A. 2018. Novel lipid signaling mediators for mesenchymal stem cell mobilization during bone repair. Cell. Mol. Bioeng. V. 11. P. 241. https://doi.org/10.1007/s12195-018-0532-0</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Shao Z., Zhang X., Pi Y., Wang X., Jia Z., Zhu J., Dai L., Chen W., Yin L., Chen H., Zhou C., Ao Y. 2012. Polycaprolactone electrospun mesh conjugated with an MSC affinity peptide for MSC homing in vivo. Biomaterials. V. 33. P. 3375. https://doi.org/10.1016/j.biomaterials.2012.01.033</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Sheyn D., Shapiro G., Tawackoli W., Jun D.S., Koh Y., Kang K.B., Su S., Da X., Ben-David S., Bez M., Yalon E., Antebi B., Avalos P., Stern T., Zelzer E. et al. 2016. PTH induces systemically administered mesenchymal stem cells to migrate to and regenerate spine injuries. Mol. Ther. V. 24. P. 318. https://doi.org/10.1038/mt.2015.211</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Spaas J.H., De Schauwer C., Cornillie P., Meyer E., Van Soom A., Van de Walle G.R. 2013. Culture and characterisation of equine peripheral blood mesenchymal stromal cells. Vet. J. V. 195. P. 107. https://doi.org/10.1016/j.tvjl.2012.05.006</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>Struzyna J., Pojda Z., Braun B., Chomicka M., Sobiczewska E., Wrembel J. 1995. Serum cytokine levels (IL-4, IL-6, IL-8, G-CSF, GM-CSF) in burned patients. Burns. V. 21. P. 437. https://doi.org/10.1016/0305-4179(95)00018-7</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>Tang Y., Xia H., Kang L., Sun Q., Su Z., Hao C., Xue Y. 2019. Effects of intermittent parathyroid hormone 1-34 administration on circulating mesenchymal stem cells in postmenopausal osteoporotic women. Med. Sci. Monit. V. 25. P. 259. https://doi.org/10.12659/MSM.913752</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation>Tatsumi K., Ohashi K., Matsubara Y., Kohori A., Ohno T., Kakidachi H., Horii A., Kanegae K., Utoh R., Iwata T., Okano T. 2013. Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism. Biochem. Biophys. Res. Commun. V. 431. P. 203. https://doi.org/10.1016/j.bbrc.2012.12.134</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation>Teo G.S., Ankrum J.A., Martinelli R., Boetto S.E., Simms K., Sciuto T.E., Dvorak A.M., Karp J.M., Carman C.V. 2012. Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms. Stem Cells. V. 30. P. 2472. https://doi.org/10.1002/stem.1198</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation>Uder C., Brückner S., Winkler S., Tautenhahn H.M., Christ B. 2018. Mammalian MSC from selected species: Features and applications. Cytometry A. V. 93. P. 32. https://doi.org/10.1002/cyto.a.23239</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation>Ullah M., Liu D.D., Thakor A.S. 2019. Mesenchymal stromal cell homing: mechanisms and strategies for improvement. iScience. V. 15. P. 421. https://doi.org/10.1016/j.isci.2019.05.004</mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation>Vanden Berg-Foels W.S. 2014. In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment. Tissue Eng. Part B Rev. V. 20. P. 28. https://doi.org/10.1089/ten.TEB.2013.0100</mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation>Van der Velden D.L., Houthuijzen J.M., Roodhart J.M.L., van Werkhoven E., Voest E.E. 2018. Detection of endogenously circulating mesenchymal stem cells in human cancer patients. Int. J. Cancer. V. 143. P. 2516. https://doi.org/10.1002/ijc.31727</mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation>Vieira C.P., McCarrel T.M., Grant M.B. 2021. Novel methods to mobilize, isolate, and expand mesenchymal stem cells. Int. J. Mol. Sci. V. 22. P. 5728. https://doi.org/10.3390/ijms22115728</mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation>Wan M., Li C., Zhen G., Jiao K., He W., Jia X., Wang W., Shi C., Xing Q., Chen Y.F., Jan De Beur S., Yu B., Cao X. 2012. Injury-activated transforming growth factor beta controls mobilization of mesenchymal stem cells for tissue remodeling. Stem Cells. V. 30. P. 2498. https://doi.org/10.1002/stem.1208</mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation>Wang M., Chen F., Wang J., Chen X., Liang J., Yang X., Zhu X., Fan Y., Zhang X. 2018. Calcium phosphate altered the cytokine secretion of macrophages and influenced the homing of mesenchymal stem cells. J. Mater. Chem. B. V. 6. P. 4765. https://doi.org/10.1039/c8tb01201f</mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation>Wiegner R., Rudhart N.E., Barth E., Gebhard F., Lampl L., Huber-Lang M.S., Brenner R.E. 2018. Mesenchymal stem cells in peripheral blood of severely injured patients. Eur. J. Trauma Emerg. Surg. V. 44. P. 627. https://doi.org/10.1007/s00068-017-0849-8</mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation>Wu C.C., Wang I.F., Chiang P.M., Wang L.C., Shen C.J., Tsai K.J. 2017. G-CSF-mobilized bone marrow mesenchymal stem cells replenish neural lineages in Alzheimer’s disease mice via CXCR4/SDF-1 chemotaxis. Mol. Neurobiol. V. 54. P. 6198. https://doi.org/10.1007/s12035-016-0122-x</mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation>Yang J.W., Zhang Y.F., Wan C.Y., Sun Z.Y., Nie S., Jian S.J., Zhang L., Song G.T., Chen Z. 2015. Autophagy in SDF-1α-mediated DPSC migration and pulp regeneration. Biomaterials. V. 44. P. 11. https://doi.org/10.1016/j.biomaterials.2014.12.006</mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation>Zhang D., Jiang M., Miao D. 2011. Transplanted human amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse. PLoS One. V. 6. P. e16789. https://doi.org/10.1371/journal.pone.0016789</mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation>Zhou S.B., Wang J., Chiang C.A., Sheng L.L., Li Q.F. 2013. Mechanical stretch upregulates SDF-1α in skin tissue and induces migration of circulating bone marrow-derived stem cells into the expanded skin. Stem Cells. V. 31. P. 2703. https://doi.org/10.1002/stem.1479</mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation>Zhou T., Yuan Z., Weng J., Pei D., Du X., He C., Lai P. 2021. Challenges and advances in clinical applications of mesenchymal stromal cells. J. Hematol. Oncol. V. 14. P. 24. https://doi.org/10.1186/s13045-021-01037-xa</mixed-citation></ref></ref-list></back></article>
